Company page

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. is a public company listed under the ticker HRMY, operating in the American market. The company has a market capitalization of approximately $2.04 billion. Harmony Biosciences focuses on developing treatments for neurological disorders, aiming to improve the quality of life for patients.

HRMY:NASDAQUpdated July 31, 2026
Harmony Biosciences Holdings, Inc. logo
Ticker
HRMY:NASDAQ
Asset type
Stock
Market cap
$2.04B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD